Emmanouil Sifakis

Karolinska Institutet

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (15)

Collaborators (6)

Narsis Kiani

Karolinska Institutet

Nikolas Herold

Karolinska University Hospital

Roxanna Hellgren

Karolinska Institutet

Xinsong Chen

Karolinska University Hospital

Apple Tay

Karolinska Institutet

Rolf Ohlsson

senior professor

Karolinska Institutet

Emmanouil Sifakis

Research Interests

Explore related searches

Contact this professor

Articles (15)

Collaborators (6)

Narsis Kiani

Nikolas Herold

Roxanna Hellgren

Xinsong Chen

Apple Tay

Rolf Ohlsson

How do I reach out?

Meet Kite AI

Emmanouil Sifakis

Research Interests

Explore related searches

Contact this professor

Articles (15)

Computational pathology annotation enhances the resolution and interpretation of breast cancer spatial transcriptomics data.

Abstract P4-01-30: Proteogenomic profiles of HER2-positive breast cancer and response to neoadjuvant anti-HER2 treatment

BreastSubtypeR: Streamlining Intrinsic Molecular Subtyping in Breast Cancer Research with a User-Friendly R Package

Gene Expression patterns in early ER+/HER2-breast cancer treated with neoadjuvant chemotherapy versus CDK4/6 inhibitor therapy: results from the Swedish PREDIX Luminal B trial

20P Evolution of early-stage ERBB2-mutant, HER2+ breast cancer under neoadjuvant therapy

30P Novel integrated tumor micro-/macro-environment (TMME) subtypes for prediction of treatment response to neoadjuvant anti-HER2 therapy

4MO Development and validation of CDKPredX, a novel predictor of response to neoadjuvant endocrine therapy and CDK4/6 inhibitors versus chemotherapy in ER+/HER2- breast cancer: Correlative analysis of the randomized phase II PREDIX luminal B trial

55P Single-nucleotide polymorphisms associated with haematological toxicities during adjuvant chemotherapy in high-risk early breast cancer patients: Results from the PANTHER phase III trial

77P The landscape of somatic mutations in high-risk early ER+/HER2- breast cancer patients: Analysis of the randomized phase II PREDIX luminal B trial

Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancer.

Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction

Author Correction: WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating

MYC as a driver of stochastic chromatin networks: implications for the fitness of cancer cells

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease

PD-1 protein and gene expression as prognostic factors in early breast cancer

Collaborators (6)

Narsis Kiani

Nikolas Herold

Roxanna Hellgren

Xinsong Chen

Apple Tay

Rolf Ohlsson

How do I reach out?

Meet Kite AI